EB vs REGN · rev $291.8M vs P/E 14, rev $14.34B
Eventbrite Inc Class A (EB) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Eventbrite Inc Class A (EB) is a internet content & information company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EB revenue for 2025-12-31 was $291.8M. Net income was -$10.5M. Revenue was down 10.2% from 2024-12-31 to 2025-12-31. EB currently screens at market cap $453.0M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EB currently screens at market cap $453.0M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EB and REGN stock pages for the full models.
Not investment advice.